FREE SHIPPINGon all orders over €80 Delivery 4-7 Days
×
View Cart
Your shopping cart is empty!
Search
Alzheimer's disease is one of the most common forms of dementia, affecting millions of people worldwide. This disease is characterized by a decline in memory and cognitive abilities, which can lead to a significant decrease in quality of life. Despite significant efforts in research, there is currently no effective treatment for Alzheimer's disease
Despite significant efforts in research, there is currently no effective treatment for Alzheimer's disease. However, a new study conducted in the United Kingdom has shown that drugs for treating erectile dysfunction, such as Viagra and Cenforce, Vilitra, Tadacip, Vidalista, may reduce the risk of developing Alzheimer's disease.
The study involved approximately 270,000 men who had been diagnosed with erectile dysfunction and had no cognitive problems at the beginning of the study. About 55 percent of the men were taking drugs such as sildenafil (Viagra), tadalafil (Cenforce, Vilitra, Tadacip, Vidalista), vardenafil, and avanafil, which are known as phosphodiesterase type 5 inhibitors and act by dilating blood vessels.
The study found that men taking drugs for treating erectile dysfunction, such as Viagra and Cenforce, Vilitra, Tadacip, Vidalista, were 18 percent less likely to develop Alzheimer's disease. This gives hope that these drugs may be used for the prevention of a common form of dementia. However, additional clinical trials are needed to establish a causal link.
Despite the promising results of the study, further research is needed to confirm these findings, learn more about the potential benefits and mechanisms of action of these drugs, and investigate the optimal dosage. Researchers also believe that a randomized controlled trial involving both sexes could help confirm the direct link between the drugs and a reduction in the risk of developing Alzheimer's disease.
The new study has shown that drugs for treating erectile dysfunction, such as Viagra and Cenforce, Vilitra, Tadacip, Vidalista, may reduce the risk of developing Alzheimer's disease. However, further research is needed to confirm these findings and determine the optimal dosage. Additionally, a randomized controlled trial involving both sexes should be conducted to confirm the direct link between the drugs and a reduction in the risk of developing Alzheimer's disease.
By signing up, you agree to our Terms of Use and Privacy Policy.